{"version":"1.0","type":"link","title":"Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance.","author_name":"Schmidt C 외","author_url":"https://prs-insight.online/author/Schmidt%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/165704","thumbnail_width":1200,"thumbnail_height":630}